LIFEMD, INC. Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
LIFEMD, INC. (LFMD) reported Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $926.53 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2020-03-30
- LIFEMD, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was $926.53K, a 2293.33% increase from fiscal 2018.
- LIFEMD, INC. cash and cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $38.71K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|
| 2019-12-31 | $926.53K 10-K · filed 2020-03-30 |
| 2018-12-31 | $38.71K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |